Tumours treated with VEGF ablation sustain changes to their vasculature, which can result in tissue oxygenation changes. This work uses dynamic oxygen enhanced MRI (dOE-MRI) to assess oxygenation of murine SCCVII tumours treated with B20-4.1.1 (murine anti-VEGF antibody) relative to controls. T1-weighted parameter maps and a modified ICA quantitative analysis technique, groupICA, describe an increase in B20-treated tumour oxygenation.
This abstract and the presentation materials are available to members only; a login is required.